Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Effect of 200μG/day of vitamin K1 on the variability of anticoagulation control in patients on warfarin: a randomized controlled trial.

Majeed H, Rodger M, Forgie M, Carrier M, Taljaard M, Scarvelis D, Gonsalves C, Rodriguez RA, Wells PS.

Thromb Res. 2013 Sep;132(3):329-35. doi: 10.1016/j.thromres.2013.07.019. Epub 2013 Jul 29.

PMID:
23953594
2.

Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.

Bussey HI, Bussey M, Bussey-Smith KL, Frei CR.

Pharmacotherapy. 2013 Nov;33(11):1136-46. doi: 10.1002/phar.1343. Epub 2013 Aug 22.

PMID:
24038412
3.

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

Ann Intern Med. 2009 Mar 3;150(5):293-300.

PMID:
19258557
4.

Low-dose vitamin K to augment anticoagulation control.

Reese AM, Farnett LE, Lyons RM, Patel B, Morgan L, Bussey HI.

Pharmacotherapy. 2005 Dec;25(12):1746-51.

PMID:
16305294
5.

Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding study.

Gebuis EP, Rosendaal FR, van Meegen E, van der Meer FJ.

Haematologica. 2011 Apr;96(4):583-9. doi: 10.3324/haematol.2010.035162. Epub 2010 Dec 29.

6.

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.

Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF.

J Thromb Haemost. 2010 Jan;8(1):95-100. doi: 10.1111/j.1538-7836.2009.03677.x. Epub 2009 Oct 30.

7.

Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysis.

Lam J, Schulman S, Witt DM, Vandvik PO, Qayyum F, Holbrook AM.

Pharmacotherapy. 2013 Nov;33(11):1184-90. doi: 10.1002/phar.1302. Epub 2013 Jun 6. Review.

PMID:
23744743
8.
9.

Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.

Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS.

Pharmacotherapy. 2000 Oct;20(10):1159-66.

PMID:
11034038
10.

Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation control.

Undas A, Cieśla-Dul M, Zółciński M, Tracz W.

Pol Arch Med Wewn. 2009 Jun;119(6):360-5.

11.

Vitamin K supplementation to decrease variability of International Normalized Ratio in patients on vitamin K antagonists: a literature review.

Ford SK, Moll S.

Curr Opin Hematol. 2008 Sep;15(5):504-8. doi: 10.1097/MOH.0b013e328304b3c5. Review.

PMID:
18695375
12.

Vitamin K for improved anticoagulation control in patients receiving warfarin.

Mahtani KR, Heneghan CJ, Nunan D, Roberts NW.

Cochrane Database Syst Rev. 2014 May 15;(5):CD009917. doi: 10.1002/14651858.CD009917.pub2. Review.

PMID:
24832594
13.

Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.

Schulman S, Parpia S, Stewart C, Rudd-Scott L, Julian JA, Levine M.

Ann Intern Med. 2011 Nov 15;155(10):653-9, W201-3. doi: 10.7326/0003-4819-155-10-201111150-00003.

PMID:
22084331
14.

Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.

Wong YM, Quek YN, Tay JC, Chadachan V, Lee HK.

J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12.

PMID:
21070296
15.

Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation.

Pengo V, Banzato A, Garelli E, Zasso A, Biasiolo A.

Blood Coagul Fibrinolysis. 1993 Oct;4(5):739-41.

PMID:
8292723
16.

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE.

Arch Intern Med. 2000 Jun 12;160(11):1612-7.

PMID:
10847254
17.

Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trial.

Kurnik D, Loebstein R, Rabinovitz H, Austerweil N, Halkin H, Almog S.

Thromb Haemost. 2004 Nov;92(5):1018-24.

PMID:
15543329
18.

The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.

Parra D, Beckey NP, Stevens GR.

Pharmacotherapy. 2007 May;27(5):675-83.

PMID:
17461702
19.

Acetaminophen and other risk factors for excessive warfarin anticoagulation.

Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE.

JAMA. 1998 Mar 4;279(9):657-62.

PMID:
9496982
Items per page

Supplemental Content

Write to the Help Desk